Semaglutide Price Drop: India Pharma Makers Ka Bada Game Changer!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorRiya Kapoor|Published at:
Semaglutide Price Drop: India Pharma Makers Ka Bada Game Changer!
Overview

Indian pharma companies ne kamaal kar diya! Jab innovator ka semaglutide patent khatam hua, toh Sun Pharma, Torrent Pharma, Dr Reddy's jaise players ne turant iska affordable generic version launch kar diya hai. Ab diabetes aur weight loss patients ke liye treatment bohot sasta ho jayega.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Patent Khatam, Toh Prices Bhi Gira Diya!

Dekho yaar, Novo Nordisk ka jo semaglutide drug tha, uska patent 20 March ko expire ho gaya. Aur iska fayda uthate hue, India ki top pharma companies ne turant action liya hai. Sun Pharma, Torrent Pharmaceuticals, Dr Reddy's Laboratories, Glenmark Pharmaceuticals, aur Alkem Laboratories sab ne apne semaglutide formulations market mein utaar diye hain. Goal simple hai: India ke badhte metabolism disorder market mein apna share pakka karna.

Prices Itni Kam Ke Aap Shock Ho Jayenge!

Sun Pharma ne toh bhai, apna weekly dose wala treatment ₹750 se lekar ₹2,000 tak mein launch kiya hai. Socho, jo medicine pehle bohot mehengi thi, ab kitni accessible ho gayi hai! Sun Pharma ke MD ne toh patient support program bhi announce kiya hai taaki patients ko treatment mein help mile. Torrent Pharma toh aur bhi aage nikli, inhone oral aur injectable dono tarah ke options de diye hain. Unke CEO ne kaha ki hum pehle Indian company hain jo yeh dual-formulation offer kar rahe hain.

India Ke Liye Yeh Kyun Hai Badi Baat?

India mein diabetes ke case toh waise hi 10 Crore se zyada hain. Aur obesity bhi ek badi problem hai. Ozempic aur Mounjaro jaise imported drugs kaafi costly hain. Semaglutide, jo blood sugar control karne aur bhookh kam karne mein help karta hai, ab India mein saste mein milne lagega. Isse lakho logo ko fayda hoga aur Indian pharma market ka scenario bhi change ho jayega.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.